Detail of "39445-21-1"

Reference

Effects of porcine pancreatic elastase on atherosclerosis: experimental and clinical studies

Effects of porcine pancreatic elastase on atherosclerosis: experimental and clinical studies. Koide, Atsushi; Shiojiri, Hiroyuki; Suzuki, Suguru; Tanabe, Yoshio; Hara, Kuniko; Issiki, Eizo; Naitoh, Haruo; Yamane, Sumitaka; Ikeda, Masanao; Mohri, Kikuo (Eisai Res. Dev. Div.In this study， 57-88-5 and 39445-21-1 are also used., Eisai Co. Ltd., Toyorato 300-26, Japan). Vasc. Neuroeff. Mech., Int. Symp., 4th, Meeting Date 1981, 369-76. Edited by: Bevan, John A. Raven: New York, N. Y. (English) 1983. CODEN: 50PUAW. DOCUMENT TYPE: Conference CA Section: 1 (Pharmacology) Porcine pancreatic elastase [39445-21-1] administration to hypercholesteremic rabbits altered the metab. of both serum lipids and arterial connective tissue macromol. when compared to that obsd. in untreated cholesterol [57-88-5]-fed controls. In patients with arteriosclerosis obliterans elastase administration significantly increased the blood flow in 22 of 30 patients. Thus, porcine pancreatic elastase may be useful clin. as a therapeutic drug for the treatment of atherosclerosis. .